Dr Matthew Plunkett joins iPierian
This article was originally published in Scrip
The US biopharmaceutical company iPierian has appointed Dr Matthew Plunkett vice-president and chief financial officer. Dr Plunkett spent the past nine years at Oppenheimer & Co, most recently as managing director where he lead the firm's biotechnology investment banking practice for the West Coast. Before that, he worked as a research scientist at Sunesis Pharmaceuticals and at Axys Advanced Technologies.